drugset / Trial / NCT00697125
Immunogenicity & Reactogenicity of Various Formulations of Recombinant Hepatitis B Vaccine With Different Adjuvants
RandomizedParallel-groupTriple-blindPrevention
Summary
The purpose of this study is to evaluate the immunogenicity and reactogenicity of various formulations of recombinant hepatitis B vaccine with different adjuvants in healthy adult volunteers following the 0, 1, 6 months schedule
Timeline
- Start
- 1993-06
- Primary completion
- 1994-07
- Completion
- 1994-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Engerix-B | Vaccine | — | Intramuscular |
| Subject | HBV-MPL vaccine 208129 | Vaccine | — | — |
| Subject | Hepatitis B vaccine | Vaccine | — | Intramuscular |